Journal articles
Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients
Norbert Vey
1
Marie Anne Hospital
Aude Collignon
Yves Collette
Daniel Birnbaum
1
Aude Charbonnier
Bilal Mohty
Evelyne d'Incan
Jerome Rey
Remy Castellano
1
Camille Montersino
1
Max Chaffanet
1
Nadine Carbuccia
1
Jose Adelaide
1
Benjamin Bouchacourt
Arnaud Guille
1
1
CRCM - Centre de Recherche en Cancérologie de Marseille (27 bd Leï Roure, BP 300059
13273 Marseille Cedex 09 - France)
- AMU - Aix Marseille Université : UM105 (Aix-Marseille Université Jardins du Pharo 58 Boulevard Charles Livon 13284 Marseille cedex 7 - France)
- Institut Paoli-Calmettes : UMR7258 (France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1068 (101, rue de Tolbiac, 75013 Paris - France)
- CNRS - Centre National de la Recherche Scientifique : UMR7258 (France)
Document type :
Journal articles
Domain :
Complete list of metadatas
https://hal-amu.archives-ouvertes.fr/hal-02143630
Contributor : Ghislain Bidaut <>
Submitted on : Wednesday, May 29, 2019 - 2:51:15 PM
Last modification on : Monday, June 1, 2020 - 1:16:02 AM
Contributor : Ghislain Bidaut <>
Submitted on : Wednesday, May 29, 2019 - 2:51:15 PM
Last modification on : Monday, June 1, 2020 - 1:16:02 AM
Links full text
Identifiers
- HAL Id : hal-02143630, version 1
- DOI : 10.1182/blood-2018-99-119263
Citation
Norbert Vey, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, et al.. Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients. Blood, 2018, 132 (1), ⟨10.1182/blood-2018-99-119263⟩. ⟨hal-02143630⟩
Metrics
Record views